12:00 AM
 | 
Aug 02, 2004
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion
Actelion (SWX:ATLN) Leerink Andrew Fein New Market outperform
Fein estimates FY04 and FY05 EPS of CHF3.24 ($2.59) and CHF4.92 ($3.94), respectively.
Angiotech (TSE:ANP; ANPI) RBC Capital Markets Douglas Miehm Upgrade Market outperform
Miehm believes that the recent recall of certain Taxus stents by partner Boston Scientific (BSX) will have only a minor...

Read the full 409 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >